The<unk> , also known as HATS, was a three-year double-blind trial involving 160 people with coronary heart disease (CHD) who had a low<unk>  and near normal LDL. The study compared a combination of simvastatin and niacin with antioxidant vitamin therapy. Using angiography, coronary artery stenosis progressed when using placebo or antioxidant alone, and regressed with the combination of simvastatin and niacin. The study demonstrated a 90% reduction in CHD death, nonfatal heart attacks, stroke, or revascularization for worsening angina. It was published in 2001.
HDL-Atherosclerosis Treatment Study
Atherosclerosis Risk in Communities
West of Scotland Coronary Prevention Study
Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial
Vitamin D and Omega-3 Trial
FACE risk profile
European Prospective Investigation into Cancer and Nutrition
Estrogen in Venous Thromboembolism Trial